---
title: "GOLLAHER DAVID L — Ownership Dossier"
canonical: https://whiteintel.dev/entity/f92c5aca-5deb-52ad-9909-da339ba1ffbe
json: https://whiteintel.dev/api/public/dossier/f92c5aca-5deb-52ad-9909-da339ba1ffbe
identifier: sec:0001752582
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# GOLLAHER DAVID L

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001752582`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/f92c5aca-5deb-52ad-9909-da339ba1ffbe  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/f92c5aca-5deb-52ad-9909-da339ba1ffbe  

## Ownership & control

### Holdings / subsidiaries

- **Cidara Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/390d0573-0eba-5945-9b14-d2e453caaa1d

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **GOLLAHER DAVID L**. Human view: https://whiteintel.dev/entity/f92c5aca-5deb-52ad-9909-da339ba1ffbe · Structured JSON: https://whiteintel.dev/api/public/dossier/f92c5aca-5deb-52ad-9909-da339ba1ffbe._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._